Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Diphenoxylate And Atropine

Diphenoxylate and Atropine: A Comprehensive 2000-Word Blog

Introduction

Diphenoxylate and atropine is a combination medication commonly prescribed for the management of acute or chronic diarrhea. Marketed under various trade names, including Lomotil, this drug is a well-established option in gastrointestinal pharmacotherapy. Diphenoxylate is a synthetic opioid that reduces gastrointestinal motility, while atropine is included in subtherapeutic doses to discourage abuse.

Pharmacological Composition and Mechanism of Action

Diphenoxylate is structurally related to the narcotic analgesic meperidine and acts by slowing intestinal motility through its effects on the smooth muscle of the gastrointestinal tract. It binds to opioid receptors in the gut wall, thereby reducing peristalsis and allowing for increased absorption of fluids and electrolytes. Atropine, a muscarinic receptor antagonist, is added in a very low dose not for therapeutic effect but as a deterrent to misuse and overdose. In higher doses, atropine causes unpleasant anticholinergic side effects, such as dry mouth, blurred vision, and tachycardia.

Therapeutic Indications

Diphenoxylate and atropine is primarily used to manage:

  • Acute non-specific diarrhea

  • Chronic diarrhea associated with conditions like irritable bowel syndrome (IBS)

  • Traveler's diarrhea (when infectious causes have been ruled out or treated)

Dosage and Administration

The usual adult dosage is 5 mg (2 tablets) of diphenoxylate with atropine four times daily. Maintenance doses can be tapered based on patient response. The medication is generally not recommended for children under the age of 6 due to safety concerns.

Clinical Efficacy

Numerous clinical trials and real-world usage have demonstrated the effectiveness of diphenoxylate and atropine in reducing stool frequency and improving stool consistency in patients with acute and chronic diarrhea. It provides symptom relief, improves quality of life, and facilitates better hydration status during diarrheal episodes.

Pharmacokinetics

Diphenoxylate is rapidly absorbed from the gastrointestinal tract and is extensively metabolized in the liver to its active metabolite, diphenoxylic acid. The onset of action occurs within 45 to 60 minutes. Both the parent drug and its metabolites are excreted primarily via the feces.

Safety Profile and Adverse Effects

Common side effects include:

  • Drowsiness

  • Dizziness

  • Dry mouth

  • Nausea

Serious but rare adverse effects:

  • Toxic megacolon (especially in patients with ulcerative colitis)

  • Respiratory depression (especially in children)

  • CNS depression

  • Allergic reactions

Contraindications and Precautions

Contraindicated in:

  • Children under 6 years of age

  • Patients with obstructive jaundice

  • Individuals with known hypersensitivity to diphenoxylate, atropine, or any component of the formulation

Precautions should be taken in:

  • Elderly patients

  • Individuals with liver or kidney impairment

  • Patients with a history of substance abuse

Drug Interactions

  • Potentiated sedative effects when combined with CNS depressants like alcohol, benzodiazepines, or barbiturates

  • Possible additive anticholinergic effects with drugs such as tricyclic antidepressants

Abuse Potential

Diphenoxylate is an opioid derivative and possesses a low-to-moderate potential for abuse, especially in large doses. The addition of atropine makes large doses unpleasant, reducing the risk of misuse.

Pediatric Considerations

Extreme caution is warranted when administering this medication to children. Severe respiratory depression and even death have been reported in pediatric patients receiving inappropriate dosages. It is typically contraindicated in children under 6 years and used with caution in older children.

Pregnancy and Lactation

The safety of diphenoxylate and atropine in pregnancy has not been well-established. It should be used during pregnancy only if clearly needed and when benefits outweigh potential risks. The presence of atropine and diphenoxylate in breast milk is not well studied, and caution is advised in nursing mothers.

Overdose and Toxicity

Symptoms of overdose include:

  • CNS depression

  • Respiratory depression

  • Flushing

  • Fever

  • Tachycardia

  • Urinary retention

Management involves symptomatic and supportive care, including activated charcoal, monitoring respiratory function, and administration of naloxone, an opioid antagonist, if indicated.

Regulatory Status and Availability

Diphenoxylate and atropine is classified as a Schedule V controlled substance in the United States, meaning it has a lower potential for abuse relative to substances in Schedules I-IV. However, it still requires a prescription.

Alternatives and Comparisons

Other antidiarrheal options include:

  • Loperamide: More commonly used due to its over-the-counter availability and lower abuse potential.

  • Bismuth subsalicylate: Useful for infectious diarrhea and traveler’s diarrhea.

  • Racecadotril: An enkephalinase inhibitor used mainly in Europe and some parts of Asia.

Recent Research and Developments

Recent studies have evaluated the efficacy of diphenoxylate/atropine in combination with antibiotics for the treatment of infectious diarrhea in travelers. Its role in managing diarrhea-predominant irritable bowel syndrome is also under ongoing investigation.

Additionally, researchers are looking into developing new formulations with a better safety profile and reduced abuse potential.

Patient Counseling and Usage Tips

Patients should be advised to:

  • Avoid alcohol and other CNS depressants while on the medication

  • Stay hydrated and consume electrolytes during episodes of diarrhea

  • Report any signs of allergic reaction or worsening symptoms

  • Not exceed prescribed dosages

  • Avoid use in children unless specifically instructed by a pediatric specialist

Conclusion

Diphenoxylate and atropine remains an important tool in the treatment of diarrhea, particularly when rapid symptom control is required. Despite its potential for abuse and side effects, careful use under medical supervision yields significant therapeutic benefits. With ongoing research and updated guidelines, its role continues to be refined in modern gastrointestinal pharmacotherapy. As always, patients should follow medical advice closely and use the drug responsibly to minimize risks and maximize benefits.

References

  1. FDA Prescribing Information for Lomotil

  2. World Health Organization Model List of Essential Medicines

  3. American Gastroenterological Association Guidelines

  4. Clinical reviews on the management of acute and chronic diarrhea

  5. Peer-reviewed pharmacological literature.